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Abstract
An aging western and oriental population coupled with breakthrough advances in mod-
ern diagnostic imaging modalities has evoked renewed interest in the hitherto under-
diagnosed acute and chronic diseases of the aorta, which also include aortic aneurysm 
and aortic dissection. Although classical surgical strategies still dominate the clinical 
management of acute and chronic pathologies of the ascending aorta and the proximal 
arch region, the emergence of novel endovascular concepts has offered an interesting 
therapy alternative for the treatment of descending aortic pathology in suitable patients 
and is highly likely to evolve as the primary treatment strategy in majority of the cases. 
Moreover, the use of hybrid approaches combining surgical head-vessel debranching and 
interventional stent-graft implantation in an attempt to improve clinical outcome in aortic 
arch pathologies has helped avoid the high risk of open arch repair or complete replace-
ment. Notwithstanding these recent advancements, the complex nature of the underlying 
vascular disease still dictates that the proposed management of every diagnosed patient 
is discussed in a team constituting cardiologists, cardiac surgeons, anesthesiologists, and 
radiologists, with the conceptualization of individualized therapeutic strategies and con-
ducted in a center with significant surgical and endovascular experience.
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1. Introduction
The pathophysiological underpinnings initiating the development of thoracic aortic disease 
are complex and not fully understood. Standard treatment options in most instances have 
included surgical resection and interposition of vascular prostheses despite the risk of severe 
complications arising from surgical trauma [1–3]. Although significant advancements in sur-
gical procedures and intraoperative management have mitigated the risk of some of these 
adverse events, the perioperative mortality and morbidity remains high. Additionally, the 
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changing dynamics of demographic distribution in the western and oriental world have 
skewed the incidence of disease to an increasingly aging population, a patient group inher-
ently afflicted with a variety of comorbidities, thus foretelling the compounded risk of a sober-
ing surgical outcome.
The use of an endoluminal stent-graft prosthesis initiated as a revolutionary treatment con-
cept more than two decades ago for patients with thoracic aortic disease offered an interesting 
alternative to open surgery by circumventing certain obvious risks. The induction of recon-
structive remodeling of the diseased aorta by triggering a natural healing process through 
exclusion and depressurization of the aneurysmal process was an innovative interventional 
approach [4–6], with initial reports suggesting encouraging results for the treatment of vari-
ous aortic pathologies (e.g., degenerative aneurysm, mycotoxins aneurysm, traumatic injuries, 
aortic dissections, and penetrating aortic ulcers (PAU)). Scarce randomized data as well as the 
absence of long-term surveillance of treated patients has strengthened critique against this 
approach, and with the lack of a satisfying rebuttal, its universal adoption has consequently 
been hindered [7–10]. This comprehensive chapter describes current indications, techniques, 
and advancements in endovascular strategies in the treatment of thoracic aortic disease.
2. Classification
Aortic dissection and aortic aneurysm have been listed as the most commonly encountered 
pathologies of the thoracic aorta. The incidence of aortic dissection in the clinical arena is still 
relatively rare, with an estimated 2.6–4 cases per 100,000 in the general population reported 
in a year [11–13]. Statistics reveal that only around 0.5% of the patients presenting with chest 
or back pain in the emergency room (ER) suffer from aortic dissection [14]. The early phase 
of this disease, associated with significantly high mortality, is labeled an acute aortic dissec-
tion as documented symptom-onset is less than 2 weeks on presentation. Patients surviving 
the initial 2 weeks without any intervention are classified as suffering from a subacute form, 
while the chronic patients, who constitute about one-third of all patients with aortic dissec-
tion, survive longer than 90 days. The Stanford and DeBakey classifications of aortic dissec-
tion are further attempts to group different presentations according to the anatomical location 
of disease (Figure 1). The fundamental distinction lies in the presentation of either a proximal 
(involving the aortic root or ascending aorta) or distal (beyond the subclavian artery) loci. An 
untreated proximal aortic dissection is characterized by an initial mortality rate of more than 
1% per hour, which if left untreated results in death due to cardiac rupture, tamponade, heart 
failure from acute aortic regurgitation, or from major coronary closure [11–13]. The prognosis 
of a distal aortic dissection, popularly known as a Type B aortic dissection, is comparatively 
better clocking a 30-day mortality rate of about 10% [11–13].
In retrospect, little has been elucidated about the true prevalence and mortality rates of tho-
racic aortic aneurysms (TAA). An older population-based study reported an age- and gender-
adjusted incidence of 5.9 new aneurysms per 100,000 people-year in a Midwestern community 
over a 30-year period. The median ages for men and women were 65 years and 77 years, 
respectively, with the primary distribution of cases reflecting an affliction of the ascending 
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aorta in 51% of the patients, of the arch in 11% and of the descending thoracic aorta in 38% 
[15]. The Crawford classification that attempted to classify these aneurysms based on the ori-
gin of distal to the subclavian artery (Types I–IV) has recently been adapted and tweaked by 
Safi (Type V) [16] (Figure 2).
Figure 1. Classification of thoracic aortic dissection.
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3. Indications for endovascular stent-graft therapy
In the event of an aortic dissection, the sealing of proximal entry tears with a customized 
stent graft has proven to be the most effective method for excluding a growing aneurysmal 
false lumen. Although the closure of a distal reentry tear is also desirable, this is not particu-
larly necessary to achieve optimal results [12, 13, 17]. A favorable postinterventional outcome 
would constitute adequate depressurization and shrinkage of the false lumen, supplemented 
in an ideal scenario by a complete thrombosis of this lumen with consequent remodeling of 
the entire dissected aorta [18] (Figure 3).
Figure 3. Concept of interventional reconstruction of the dissected aorta with sealing of the proximal entries, 
depressurization of the false lumen, and initiation of false lumen thrombosis.
Figure 2. Classification of thoracic aortic aneurysms.
Aortic Aneurysm60
The role of percutaneous fenestration in the management of aortic dissection is debatable 
and should be in all likelihood avoided considering its profile of unproven benefits and inter-
ventional risk. The relevance of a team of professionals experienced in treating aortic dis-
ease is absolute considering the necessity for a thorough evaluation of the clinical, technical, 
Disease etiology
 Aortic aneurysms
  Atherosclerotic/degenerative
  Posttraumatic
  Mycotic
  Anastomotic
  Cystic medial necrosis
  Aortitis
 Stanford Type B aortic dissection
  Acute
  Chronic
 Giant penetrating ulcer
 Traumatic aortic tear
Aortopulmonary fistula
 Marfan syndrome
Aneurysm morphology
 Aneurysm of the descending aorta
  Proximal neck length = 2 cm
   <2 cm if supraaortic vessels have been transposed prior stent-graft placement
  Distal neck length = 2 cm
  Diameter = 6 cm
Patients condition
 Preferentially older age
 Unfit for open surgical repair or high-risk patients
  Chronic obstructive pulmonary disease
  Severe coronary heart disease
  Severe carotid artery disease
  Renal insufficiency
Suitable vascular access site
Life expectancy of more than 6 month
Table 1. Current indication for stent-graft implantation.
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and anatomical criteria before a treatment strategy has been defined. The general indication 
for emergency placement of stent grafts has been extended to scenarios where patients have 
intractable pain associated with a descending dissection, develop a rapidly expanding false 
lumen diameter, percolate extra-aortic blood (as a sign of imminent rupture), or show signs 
of a distal malperfusion syndrome [11–13] (Table 1). The use of endovascular stent grafting as 
the primary strategy may be justified in the event of late-onset complications like malperfu-
sion of vital peripheral aortic branches.
4. Anatomical measurements for thoracic aortic pathology
Multi-slice computed tomography (CT) has special relevance in the diagnosis of aortic dis-
ease. In addition to the reconstruction of a three-dimensional perspective, certain descriptive 
features of the thoracic aorta outlining the condition of the aortic wall (atheroma, calcification, 
and thrombus) as well as shape and size of the aortic pathology (diameter, length, and shape) 
need to be elucidated before the formulation of treatment strategies [19].
Although an initial CT angiography/magnetic resonance (MR) angiography is considered 
as the primary diagnostic tool for aortic pathologies, the use of transesophageal echocar-
diography and intravascular ultrasound to ascertain additional valuable information has 
also been advised. For instance, flow-sensitive MR sequences or contrast-enhanced TEE 
not only shows the communication sites between true and false lumen, but it also high-
lights the dynamic flow pattern in the false lumen prior to stent-graft placement. The use 
of contrast angiography has limited potential in this scenario as measured values are gen-
erally unreliable.
The measurement of vessel diameters is generally not defined by any set of conventional prac-
tice and operators usually refer to calculations derived from the inner vessel wall (endothelial 
trailing edge) hinging their assumption on the basis that this will guarantee some degree of 
oversizing, a potentially desirable outcome for endograft placement. Our in-house protocol 
delineates the diameter of the normal appearing proximal aorta (inner edge to edge) mea-
sured from a transverse plane perpendicular to the long axis of the aorta (preferentially from 
contrast-enhanced multi-slice CT images) (Figure 4).
The evaluation of access vessels for size and tortuosity is also pertinent because stent-graft 
delivery systems are quite large (up to 24F), and there is an associated risk of significant 
trauma to the femoral access site and iliac arteries. Severe aortic angulation or tortuosity, fri-
able atheroma or thrombus lining the aortic wall, and aortic pathology involving the ascend-
ing aorta are some features that preclude the use of thoracic stent grafts. Additionally, the role 
of appropriate peri-interventional image reconstruction in aortic arch pathology is further 
cemented when considering the placement of a stent graft for a Type B dissection, where the 
demarcation of nearby aortic branches (including the left subclavian or left common carotid 
artery) is vital.
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5. Initial treatment
An acute aortic disease is a medical emergency and suspected patients require urgent 
admission to an intensive care or monitoring unit with an emphasis on immediate diag-
nostic evaluation [20]. Initial management strategies include the treatment of pain and 
maintenance of a systolic blood pressure of 110 mmHg with the use of morphine sul-
phate and intravenous beta-blockers (metoprolol, esmolol, or labetolol), respectively. The 
use of additional anti-hypertensives like angiotensin-converting enzyme inhibitors or 
vasodilators like sodium nitroprusside has been prescribed in refractory cases, while the 
intravenous use of verapamil or diltiazem is recommended for patients in whom beta-
blockers are contraindicated. Although monotherapy with beta-blockers sufficiently con-
trols cases of mild hypertension, the addition of sodium nitroprusside at an initial dose 
of 0.3 μg/kg/min proves to be an effective combination in a severe hypertensive state. A 
careful evaluation for blood loss, pericardial effusion, or heart failure (by echocardiog-
raphy) is a prerequisite before administering volume in normotensive or hypotensive 
patients. Additionally, the control of heart rate is of utmost importance in this scenario 
[21]. Hemodynamic instability compounds to the gravity of the clinical situation, with 
patients often requiring endotracheal intubation, mechanical ventilation, and urgent bed-
side transesophageal echocardiography or rapid CT for confirmation of the provisional 
diagnosis. In rare instances, the diagnosis of cardiac tamponade as quantified by transtho-
racic echocardiography may justify an immediate sternotomy in order to obtain surgical 
access to the ascending aorta, thus reducing the risk of shock, ischemic brain damage, and 
circulatory arrest.
Figure 4. CT scan of a patient with dilated thoracic aorta. Due to the fact that the aorta follows a curved and three-
dimensionally tortuous path, the axial scans are inadequate for measuring aortic diameters, as are sagittal and coronal 
planes for measuring aortic lengths.
Role of Interventional Treatment of Thoracic Aorta
http://dx.doi.org/10.5772/66520
63
6. Technique of endovascular stent-graft placement
The use of individually selected stent grafts to cover up to 20 cm (and sometimes even more) of 
the diseased aorta relies on measurements derived from different diagnostic modalities. These 
tests also have certain additional benefits. The transesophageal echocardiography is man-
datory for detection of small entries, while contrast-enhanced CT (Computed tomography) 
angiograms have proven to be the preferred tool for diagnosis of unstable patients in an emer-
gency situation. The use of intravascular ultrasound (IVUS), using a 10 MHz ultrasound cath-
eter-mounted transducer with the potential of manual maneuverability through the diseased 
aorta, can be used to better identify communications, partial thrombosis, or other anomalies.
The operative placement of an endovascular stent graft is usually performed in a Cathlab 
or a hybrid operating room equipped with digital angiography and necessary support for 
general anesthesia (a compulsory prerequisite for all patients). The femoral artery gener-
ally serves as the access-site as it could typically accommodate a 20–24 stent-graft system. 
After the employment of the Seldinger technique to position the initial sheath, a 260 cm 
stiff wire (e.g., Amplatzer) is placed over a pigtail catheter and navigated along with a 
soft wire in the true lumen under both fluoroscopic and transesophageal ultrasound guid-
ance. The “embracement technique” augmented by the use of two pigtail catheters could 
prove useful in maintaining the true lumen during complex cases when multiple reentries 
into the abdominal aorta are required. Essentially, a catheter inserted via the left brachial 
artery navigates through the true aortic lumen and meets the femoral pigtail catheter in the 
true lumen of the abdominal aorta, thence pulling it up into the aortic arch. This technique 
ensures the definitive positioning of the stiff guide wire within the true lumen necessary 
for the ensuing endovascular intervention. The subsequent launch of the stent graft is per-
formed by carefully advancing the graft over the stiff wire in the true lumen while briefly 
maintaining a low blood pressure through rapid right ventricular pacing [22]. To improve 
apposition of the stent struts to the aortic wall in the event of incomplete sealing of the 
proximal thoracic communications, a latex balloon may be shortly inflated at the target site 
postdeployment of graft and sealing of entry flap. Doppler-ultrasound and contrast fluo-
roscopy are useful techniques instrumental in confirming the immediate result and play a 
vital role when initiating adjunctive maneuvers. The navigation of wires and instruments is 
less cumbersome in the setting of a thoracic aortic aneurysm (TAA) or aortic ulcer; however, 
meticulous intraprocedural ultrasound imaging and fluoroscopy are essential to monitor 
the interventional progress. The close vicinity of the left subclavian artery origin to the 
primary tear in Type B dissections presents a unique anatomical problem, often requiring 
a radical solution. A complete closure of the left subclavian artery (LSA) ostium may be 
necessary at times to ensure the proper placement and debranching of the stent graft, else 
use of extra-anatomical bypasses would have to be considered [23]. Observational evidence 
dictates that prophylactic surgical maneuvers are not always required but could be per-
formed electively after the endovascular intervention in the event of developing ischemia. 
Additionally, the existence of potential supra-aortic variants (e.g., presence of a lusorian 
artery, an incomplete vertebra-basilar system, or vertebral arteries directly originating from 
the arch) must be considered before the intentional occlusion of LSA [24].
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7. Device sizing and length
A key factor influencing strategies in aortic dissection and TAA interventions is the length of 
the true lumen that needs scaffolding with an endoprosthesis. The instinctual choice between 
covering primarily the proximal entry point and alternatively lining a longer length of the 
true lumen (where the descending thoracic aorta down to the level of the diaphragm is also 
treated) can significantly alter the course and prognosis of the intervention. Although a lon-
ger scaffold provides potentially greater stability and is associated with lower recurrence, the 
grave risk of potential paraplegia resulting from compromise in spinal arterial supply serves 
as the single biggest reason to avoid extensive coverage. Observational evidence indicates that 
stent-graft coverage exceeding 20 cm, previous abdominal aortic surgery, overstenting of the 
LSA, or use of the left mammary artery for coronary bypass is associated with an increased 
risk of spinal ischemia. Essentially, all scenarios leading to compromised collateral flow in the 
spinal cord arterial network are associated with an increased risk for neurological complica-
tions, thus underlining the need to avoid overstenting the LSA or use long stent grafts. The 
angiographic identification of the anterior spinal artery in this scenario has recently shown 
prognostic relevance.
The disadvantage of shorter coverage lengths is primarily associated with potential mul-
tiple reentries presenting themselves in the distal portions of the descending aorta and 
maintaining perfusion of the false lumen despite proximal entry-site closure. This deviant 
presentation can be managed by the use of uncovered bare metal stents ensuring distal 
reapposition of the dissecting lamella without any compromise to abdominal side branches 
or spinal arteries, in effect sustaining the distal extension of the scaffolding concept of 
endoluminal repair.
The proximal aspect of the device should be sized to the internal luminal diameter of the 
aorta, close to the left subclavian origin in order to achieve attachment and fixation at the 
proximal “neck.” TAA interventions may require a degree of device oversizing by about 
10–15%, while the endoprosthesis used in aortic dissection should never be oversized. Fatal 
complications are associated with excessive device oversizing, typically as a result of ensu-
ing trauma to the aortic wall, thus resulting in either a retrograde dissection into the arch or 
conversion of a Type B dissection into a Type A dissection. Cases of aortic perforation and 
formation of pseudoaneurysms have also been reported in literature. The countereffects of 
oversizing further distally into the descending thoracic aorta include the risk of tears in the 
membrane between the two channels, thus forming a new reentry point, and consequently 
sustaining the ongoing pressurized perfusion of the false lumen. However, if absolute mea-
sures do dictate the extensive scaffolding of the aortic lumen, the operator could choose to use 
two different shorter grafts instead of a single long graft. The final decision represents a com-
promise between the reduced number of modular junctions and additional frictional forces 
associated with the deployment of a long stent graft. The concurrent employment of two stent 
grafts, when deemed necessary, requires them being fashioned in a “telescopic” manner, with 
the amount of overlap exceeding 30 mm in straight anatomic segments and measuring up 
to 50 mm or more in the angulated or curved segments of the aorta. The geometry of the 
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presumed junction between the grafts provides some assistance in estimating the length of 
overlap required at the connecting zones. A key deciding factor in this situation is the length 
of the radius of the curve, with shorter radii requiring a longer stent overlap on the lesser 
curve. Another prominent factor influencing the decision regarding overlap is the degree of 
support provided by the native aorta at the modular junction. If the junction occurs in the sac 
of a large fusiforme aneurysm rather than in a segment of aorta with a normal diameter, the 
required overlap should be longer. The reason for this approach is a tendency for the graft 
to move out toward the greater curve of the aneurysmatic aortic segment due to mechanical 
forces associated with the pulsatile motion of the aorta, potentially causing a migration or a 
disconnection of the modular components.
8. Extended scaffolding with bare stents
The general consensus on management of entry tears dictates treatment with a covered stent 
graft, while the remaining distal thoracic or even abdominal aorta may be additionally sup-
ported by uncovered stents [25]. In selecting the suitable stent graft, the following principles 
should be followed:
 - An appropriate size and diameter is crucial to avoid erosion through the aortic wall and 
to assure optimal conformability.
 - The flexibility of the endoprosthesis and its release with a deployment mechanism should 
permit ease of use and provide accurate placement at the desired zone.
 - The fragility of the dissected wall directs the use of a stent graft that is not dependent on bal-
loon expansion for deployment or postdeployment modeling. Our experience suggests that 
the use of a self-expanding endoprosthesis with a nitinol-based architecture using limited 
radial force (in case of aortic dissection) is helpful in avoiding any untoward ballooning.
9. Landing zone
The three-dimensional mechanical forces associated with the pulsatile flow that “play” on 
an endoprosthesis in the thoracic aorta are far greater and more complex than those in the 
abdominal aorta. It is for this reason that an extremely stable graft-anchorage and optimal 
graft-apposition are prerequisites for a satisfying result. The proximal and distal landing 
zones should ideally be free of aortic wall atheroma or thrombi and circumscribe 15 mm 
in length. The contemporary hypothesis suggesting that the left subclavian artery is a nat-
ural barrier beyond which it is impossible to deploy stent grafts has been now rendered 
redundant.
The suitable presentation of the aortic arch between the left subclavian artery and the origin 
of the left common carotid artery, coupled with its relatively horizontal orientation in com-
parison to the aorta distal to the LSA, has encouraged interventionists to use this segment 
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of the aorta as a preferred anchor zone (with or without bypassing the LSA). To ascertain 
optimal cerebral circulation, it is considered prudent to perform a preinterventional digital 
subtraction angiography (DSA), CT, or magnetic resonance angiography. This could help 
identify patients with an incomplete circle of Willis or other limitations or abnormalities of 
cerebral vascular supply. In patients affected with a cerebrovascular pathology, prophylactic 
measures such as carotid-subclavian bypass might be considered prior to the stent-associ-
ated covering of the LSA. An obvious alternative is the use of bare stents proximally for bet-
ter alignment while foregoing the risk of occluding a vital branch.
10. Hybrid arch procedures
The relative proximity of supra-aortic branches needing preservation poses a strict interventional 
challenge, considering that the aortic arch anatomy and pathology is complicated by varying 
degrees of length and angulation [26–28]. The traditional open arch surgical reconstruction tech-
niques requiring perioperative hypothermic cardiac arrest, extracorporeal circulation, and selec-
tive cerebral perfusion have been shown to manage aortic arch pathologies effectively. However, 
these major surgical procedures carry the risk of significant mortality, paraplegia, and cerebral 
stroke. Younger patients with a smaller risk-profile qualify for such an open repair, while high-
risk patients constitute the group of candidates ill-suited for this surgical approach. Hybrid arch 
procedures are a combination of methods preserving cerebral perfusion (like the debranching 
bypass with supra-aortic vessel transposition) on the one hand, while objectively providing 
patient-centric solutions for complex aortic arch lesions through thoracic endografting on the 
other (Figure 5). Hybrid arch procedures are performed without hypothermic circulatory arrest 
or extracorporeal circulation, thus expanding the treatable population demographic to older and 
high-risk patients with severe comorbidities currently not eligible for open surgical repair.
Figure 5. Contrast-medium enhanced MR-angiography of the aorta in a case of an arch aneurysm. (a) Aneurysm of the 
aortic arch involving the supra-aortic branches. (b) Result after hybrid procedure with debranching of the supraaortic 
vessels and stent-graft placement in the aortic arch.
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11. Aftercare and long-term follow-up
The long-term care of patients successfully treated for an acute aortic dissection is pivoted on 
the appreciation of this disease as a systemic illness. Estimates suggest that nearly one-third 
of patients surviving an acute dissection of the thoracic aorta will either experience complica-
tions like extension of the dissection and late aortic rupture or require surgical correction of 
a newly formed aortic aneurysm, within 5 years of initial presentation [29]. All patients merit 
aggressive medical therapy, follow-up visits, and serial CT-imaging. The medical manage-
ment of these patients is primarily centered on therapy with beta-blockers, in essence serving 
as the cornerstone of successful aftercare. High blood pressure values and steeper curves 
representing changes in the blood volume and pressure (dp/dt) have been shown to acceler-
ate aortic expansion in Marfan’s syndrome and also in patients with chronic abdominal aortic 
aneurysms (AAA). The aim in patients with thoracic aortic disease is to balance blood pres-
sure values to less than 135/80 mmHg, while patients diagnosed with Marfan’s syndrome are 
advised to maintain blood pressure levels below 130/80 mmHg [11–13]. Additionally, an ade-
quate control of heart rate under 60 beats per minute has been associated with significantly 
fewer secondary adverse events (aortic expansion, recurrent aortic dissection, aortic rupture, 
and/or need for aortic surgery) in Type B aortic dissection patients [21].
Serial CT imaging of the aorta is an essential component of long-term management (before 
and after surgery or stent-graft placement). The choice of imaging modality, CT or magnetic 
resonance, is dependent on institutional availability and expertise. Past recommendations 
have suggested follow-up imaging at 1-, 3-, 6-, 9-, and 12-month intervals following discharge, 
and annually thereafter [11–13]. This aggressive strategy, in effect, underlines the observation 
that both hypertension and aortic expansion/dissection are common and not easily predicted 
in the first months following hospital discharge. The risk of dissection progression and aneu-
rysm formation anywhere along the entire length of the aorta cements the need for consistent 
follow-up imaging of the complete thoracic aorta and in exceptional cases, imaging of the 
thoracoabdominal as well as abdominal aorta.
12. Management of complications
12.1. Endoleaks
An endoleak is a condition defined by the persistence of blood flow outside the endovascu-
lar stent-graft lumen, contained within the aneurysm sac, or in certain cases adjacent to the 
vascular segment treated by the stent graft. Endoleaks generally persist for a long duration, 
with a few eventually developing a late aneurysmal rupture, while some may also resolve and 
close spontaneously.
The classification of endoleaks according to time of onset permits their grouping into “pri-
mary endoleaks,” when it occurs during the perioperative period (lesser than 30 days) or 
secondary leak when it is detected later. Further subcategorization requires precise informa-
tion on periprosthetic blood flow. A Type I endoleak is an indicator of a persistent perigraft 
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channel of blood flow caused by an inadequate seal at either the proximal (I-a) or distal (I-b) 
stent-graft end or attachment zones. A Type II endoleak is attributed to retrograde flow into 
the aneurysmal sac via aortic side branches, while a Type III endoleak is caused by compo-
nent disconnection (III-a) or fabric tear, fabric disruption, or graft disintegration (III-b). Type 
III-b can be further stratified as minor (<2 mm), or major (>2 mm). The Type IV endoleak is 
caused by blood flow through an intact but otherwise porous fabric, observed during the 
first 30 days after stent-graft implantation. If an endoleak is detected on imaging studies 
but the precise source cannot be determined, the endoleak is categorized as an endoleak of 
undefined origin.
Various strategies have been outlined for the treatment of endoleaks. The conservative line of 
management, essentially constituting strict observation and follow-up is especially suggested 
for Type II and Type IV endoleaks. An endovascular reintervention (e.g., balloon-inflation 
and/or implantation of an additional stent graft) is suggested for the management of Type I 
and Type III endoleaks. If these endovascular maneuvers fail in their attempt to exclude the 
aneurysm from circulation, the resulting increase in TAA-diameters could be corrected by 
open surgery.
13. Aneurysm evolution after stent-graft treatment
The thoracic aorta is defined by a set of unique anatomical features and habits a distinctive 
biomechanical and hemodynamic environment, which explains some of the rare late compli-
cations specific to device use seen in this region. The descending thoracic aorta, unlike the 
abdominal aorta, is relatively mobile in the thorax and is subject to complex and vigorous three-
dimensional motion. The only points of fixation are the aortic root and sites of origin of major 
branches, thereby permitting the mobility of a long aortic segment extending from the LSA to 
the celiac artery. This contributes to the elongation, angulation, and eventual enlargement of 
the thoracic aorta between these points, thus promoting the development of an aneurysm. The 
mechanical forces exert a complex pattern of dynamic circumferential, radial, and axial forces 
on thoracic stent grafts, resulting in a stress field significantly different than that exerted on 
abdominal stent grafts. It is, however, still relatively rare to see aneurysms develop in the dis-
sected aorta post stent-graft treatment. The relevance of strict clinical and imaging follow-up 
to monitor anatomical changes in the thoracic aorta is highlighted by the fact that the develop-
ment of a false lumen thrombosis secondary to thoracic endografting is essential to the preven-
tion of late aortic expansion.
A pertinent issue of concern is the fate of the distal aortic segment despite successful thoracic 
stent-graft placement. In the presence of large reentry points, the thoracoabdominal segment 
of the false lumen has a tendency to remain patent and remodel completely, setting the stage 
for late complications such as aneurysmal enlargement at the proximal or distal end of the 
stent graft. Some other complications include perforations of the fragile aortic intima by the 
ends of the metallic stent (especially in the early phase of acute aortic dissection), and inju-
ries caused by stiff guide-wires and device manipulation potentially setting the stage for an 
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 evolving aneurysm. The risk of these complications is noticeably diminished by the introduc-
tion of a more flexible and soft tip delivery system aided by minimally traumatic thoracic 
guide-wires specifically designed for these interventions. Additionally, the time required to 
perform an endovascular intervention could provide insight to complications such as stroke 
or bleeding; both of which could be significantly reduced by experienced interventionists 
requiring less than 30 min to complete a case. It has been also suggested that the patency of 
the abdominal aortic false lumen may be related to persisting communications between the 
true and false lumen. Treatment of these communications at the level of distal thoracic and 
abdominal aorta could potentially obliterate the false lumen and reduce the aortic diameter. 
In clinical practice, however, the closure is difficult to achieve because of the proximity or 
involvement of the visceral branches. Another late complication of graft treatment is related to 
the mechanical weakness of dissected aortic walls causing distention of the aorta beyond the 
portion covered by the stent graft. Prevention of these complications can be partially achieved 
during the primary procedure by ensuring adequate landing zones proximal and distal to the 
stent graft, and closure of large fenestrations along the length of the false lumen. The use of a 
provisional bare metal stent as a distal extension to the stent graft has been reported to facili-
tate aortic remodeling and help completely repair the distal dissected segments without com-
promising important side-branches (Provisional Extension To Induce Complete Attachement 
after stent-graft implantation (PETTICOAT) technique) [25]. This would address the problem 
of persistent perfusion within the false lumen as well as any increase in aneurysmal size.
14. Stent-graft infection
The infected prosthetic graft represents a rare complication that could be difficult to diagnose 
despite extensive work up, with consensus reached only after thorough analysis of imag-
ing, hematological, and clinical parameters. The presence of air, soft tissue accumulation, 
and progressive enlargement of the aneurysm sac is usually pathognomonic, and suspicious 
changes spotted in imaging coupled with raised markers of systemic inflammation and clinical 
symptoms are generally suggestive of an infective process. The diagnostic use of positron 
emission tomography (PET) radionuclide studies is a helpful tool in most cases. Prior to initi-
ation of treatment against thoracic endograft infections, data concerning diagnostic certainty, 
pathogenesis of the infecting microbe, the extent of infection, the presenting features, and the 
medical co-morbidities of a given patient need to be evaluated.
As with the treatment of all prosthetic graft infections, multiple management strategies have 
been proposed in this scenario. These include a conservative line of treatment with targeted 
intravenous antibiotics or also alternatively by direct puncture and application into the peri-
graft space; insertion of another stent graft into the potentially infected graft or excision of 
the infected stent graft with debridement of the surrounding tissue; and in-situ/extra-ana-
tomic vascular reconstruction. Irrespective of the applied strategy, the treatment of aortic 
graft infection remains difficult and problematic. In the absence of management algorithms 
defining treatment strategies in the varying forms of presentation and degrees of infection, 
individualized therapies need to be devised while weighing the risks in each scenario. In 
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general, a decision must be made as to whether treatment is to be potentially curative or pal-
liative. The curative treatment approach encompasses an aggressive open surgery, justified 
only in certain cases in lieu of the relatively high mortality associated with the procedure.
The palliative approach suggests placement of an endovascular graft (graft-in-graft approach) 
thereby preventing the risk of life-threatening bleeding or fistulation. Patients with complex 
graft disease should always be treated in experienced centers equipped to conduct all treat-
ment variations.
15. Retrograde Type A dissection following stent-graft placement
There have been cases reporting a proximal aortic dissection after placement of an endograft; 
the incidence of this complication, according to existing data, ranges presumably between 1 
and 2% and generally occurs shortly after the intervention [30, 31]. Chest pain or symptoms 
of an ischemic heart or brain should immediately alert the suspicion that a Type B dissec-
tion has modified itself to a Type A dissection, with a higher morbidity and mortality risk. 
An emergency Computed tomography angiography (CTA) and subsequent surgery are the 
only lifesaving options for the patient. There are several reasons why Type A dissections may 
occur after stent-graft placement in the descending thoracic aorta (Table 2).
In these cases, it is of absolute importance to advance the guide-wire, catheter, and endograft 
in the true lumen only. If doubts persist concerning the correct positioning of the guide wire 
(in the true or false lumen), the use of angiography and transoesophageal echocardiography 
is instrumental before initiation of the next step. Signs differentiating the true from the false 
lumen include luminal size, where the false aortic lumen is usually larger than the true lumen, 
as well as flow at entry, which is generally directed into the false lumen. This explains the 
damping of the pulse amplitude and a poorly palpable pulse in many of these patients.
Precise measurement of the proximal aortic dimensions is essential for the selection of the 
size of stent graft and successful sealing of aortic tears. In Type B dissection, the stent graft is 
The initial misinterpretation of a Type A dissection as a Type B dissection
Spread of the dissection into the ascending aorta or aortic arch due improper placement of the stent graft relatively 
distant to the LSA, or the possible maneuvering into the false lumen
Under- or oversizing of the stent graft, with consequent leaks or additional injuries to the aortic wall
Malapposition of the stent graft to the aortic wall at the proximal landing zone resulting in subsequent collapse of the 
proximal stent graft
Ballooning of the proximal end of the stent graft resulting in injury of the diseased aortic wall, thus causing the 
extension of the dissection in the aortic arch and ascending aorta
Development of a Type A dissection independent of the existing Type B dissection
Table 2. Cause of Type A aortic dissection after stent-graft implantation.
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normally placed with its proximal end directly at the origin of the LSA. The proximal landing 
of a stent graft is usually close to the LSA, even though the tear could be in the middle por-
tion; so performed, when considering the possibility of a dissection membrane developing a 
new tear between LSA and proximal end of the stent graft. In successful cases, angiography 
demonstrates a good result with complete sealing of the leak and absence of signs showing 
renewed opacification of the false lumen. Occasionally, a stiff endograft chafes on the fragile 
dissection membrane and a new endoleak may develop. This could possibly require addi-
tional stent grafting or eventually lead to open surgery.
16. Paraplegia after stent-graft placement
The risk of spinal cord ischemia is of significant concern post stent-graft placement as there 
is a frequent need to cover multiple intercostal arteries as also the artery of Adamkiewitz (the 
single prominent intersegmental branch from the aorta at the lower thoracic or upper lumbar 
level). Interestingly, around 3–12% of the stent-graft patients treated for aneurysms, dissec-
tions, ulcers, intramural hematoma, or aortic traumatic transsection are at risk to develop 
spinal cord ischemia. Although occlusion of important radicular arteries that originate from 
vertebral, intercostal, and lumbar arteries is primarily responsible for ischemia of the spi-
nal cord, associated factors such as ischemia-reperfusion and hypotension may also play a 
causal role in the development of paraplegia. This is a telling contradiction to the widely 
held impression that the coverage of the segmental artery or the orifices of the intercostal/
interlumbar arteries by the stent graft represents the single possible and most critical cause of 
spinal ischemia. Measures to prevent occurrence of paraplegia in stent-graft patients should 
include several aspects (Table 3).
Symptoms of paraplegia or paraparesis could be possibly reversed if a spinal tap is intro-
duced without any delay and arterial perfusion pressure is maintained at a systolic pressure 
of 140 mmHg by pharmacological means or volume replenishment.
Screening for high-risk patients
o Age > 75
o Anticipated endograft coverage between T9 and T12 (location of anterior spinal artery)
o Coverage of long segment (>20 cm)
o Compromised collateral pathways (e.g., LIMA as coronary artery bypass, infrarenal surgical aortic repair)
o Long extent of atherosclerotic lesions
-Early detection of spinal cord ischemia
o Somatosensory-evoked potentials
o Motor-evoked potentials
-Monitoring of cerebral or spinal cord perfusion and drainage (spinal tap decreases intrathecal pressure to 10–15 cm 
H
2
O to generate space for collateral arteries to fill and perfuse better)
-Prevention of perioperative hypotension
Table 3. Factors influencing the rate of paraplegia.
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17. Stroke after stent-graft placement
Stroke is a grave complication occurring post stent-graft replacement and reports of incidence 
vary between 0 and 18%. The instrumentation in the aortic arch has been known to produce 
an embolic shower in the brain, and the use of guidewires and catheters as well as bulky 
delivery systems carrying the stent grafts in endovascular interventions in this region supple-
ments to the risk. The need for balloon dilatation of stent grafts adds to the possibility of dis-
lodgement of particles from the aortic arch. It is also well known that proper flushing of the 
stent-graft delivery system does not guarantee the elimination of air contained in the crimped 
stent graft. Moreover, bubbles are also released with the deployment of the stent graft. The 
confirmation of an open contralateral vertebral artery with correct formation of the basilar 
trunk and absence of intracranial branch anomalies is a basic prerequisite in patients in whom 
subclavian artery closure is considered.
In summary, there is an absolute need to completely define the left vertebral artery with 
depiction of its origin, patency, and size, as well as the size and condition of the right verte-
bral artery including the constitution of the basilar artery and its branches before conducting 
a procedure involving the closure of the LSA. In patients with compromised cerebral circula-
tion, prior diagnosis of the four vessels with cerebral angiography is the recommended stan-
dard. When the left vertebral artery takes off from the aortic arch, occlusion of the LSA can 
result in severe ischemia of the left arm. If the left vertebral artery takes off from an aneurysm 
that is being excluded, it could result in a Type II endoleak, a severe steal phenomenon or 
even present as an ipsilateral posterior stroke. In such cases, a transposition of the LSA prior 
to the intervention is required.
18. Conclusions
Endovascular stent grafting represents an exciting therapeutic advancement and has emerged 
as an alternative therapy to open surgical repair in thoracic aortic pathologies. Although it is 
apparent that high-risk patients will benefit from this technology, the exact role of stent graft-
ing needs to be defined as long-term data is constantly accumulated and analyzed, and further 
influenced by evolving devices and technology. Rather than replacing conventional surgical 
treatment, endovascular repair will likely play a complementary role and offer a less invasive 
option in the treatment armamentarium. Clearly, there are limitations to both approaches; 
however, while high-risk surgery is defined by clinical parameters, comorbidities and physio-
logical reserve, contraindications for endovascular stent-graft treatment are defined mostly by 
anatomical criteria such as a too wide aorta to provide landing zones for an endoprosthesis or 
already irreversible paraplegia. Nevertheless, treatment should be carried out only in a center 
with experience in both endovascular and surgical procedures, and with adequate technical 
facilities. Treatment of thoracic aortic pathologies should be subject to prior multidisciplinary 
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discussion, particularly with regard to risks of conversion and need for cardiopulmonary 
bypass. All patients should have access to a structural follow-up plan offering both regular 
clinical assessment and professional imaging follow-up by CT or MR angiography.
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